Funding for this research was provided by:
Received: 11 January 2020
Accepted: 3 July 2020
First Online: 23 July 2020
Ethics approval and consent to participate
: The study was carried out in accordance with the latest version of the Declaration of Helsinki and approved by the Ethics Commission of the Faculty of Human Science, University of Bern.All participants were informed in written form about the topic and procedure of the study. Participants in the exposure agreed to participate by signing an informed consent, the online survey participants by clicking on the “start” button. Exclusion criteria were current psychiatric or neurological disorders, and a neurotropic medication.
: Not applicable.
: BZ, MMJ, and JCS (full disclosure) report grants from Orion Pharma, Abbott Nutrition International, B. Braun Medical AG, CSEM AG, Edwards Lifesciences Services GmbH, Kenta Biotech Ltd, Maquet Critical Care AB, Omnicare Clinical Research AG, Nestle, Pierre Fabre Pharma AG, Pfizer, Bard Medica S.A., Abbott AG, Anandic Medical Systems, Pan Gas AG Healthcare, Bracco, Hamilton Medical AG, Fresenius Kabi, Getinge Group Maquet AG, Dräger AG, Teleflex Medical GmbH, Glaxo Smith Kline, Merck Sharp and Dohme AG, Eli Lilly and Company, Baxter, Astellas, Astra Zeneca, CSL Behring, Novartis, Covidien, and Nycomed outside the submitted work. The money was paid into departmental funds. No personal financial gain applied. All other authors declare no conflict of interest.